How Targeted Muscle Reinnervation Was Developed

Targeted muscle reinnervation (TMR) is a surgical nerve-transfer procedure that was developed by Dr. Todd Kuiken at Northwestern University and Rehabilitation Institute of Chicago and Dr. Gregory Dumanian at Northwestern University Division of Plastic Surgery. TMR was developed to provide amputees with more intuitive control of upper-limb prostheses by combining available technology with modifications of the residual limb anatomy. The procedure involves transferring residual nerves from the amputated limb to new muscle targets, allowing them to reinnervate the muscle and restore its function. TMR has been found to not only improve control of prostheses but also to help relieve phantom limb pain and neuroma pain in amputees.

Explore related products

Targeted Muscle Reinnervation: A Neural Interface for Artificial Limbs (Series in Medical Physics and Biomedical Engineering)

$270 $84.99

Temporomandibular Joint Total Joint Replacement – TMJ TJR: A Comprehensive Reference for Researchers, Materials Scientists, and Surgeons

$189 $199.99

Myocardial Laser Revascularization

$99 $123.95

Reinnervation: Webster's Timeline History, 1943 - 2007

$28.95

Motor Unit Properties Following Cross-reinnervation of Cat Triceps Surae Muscles

$93

Targeted muscle reinnervation (TMR) was developed by Dr. Todd Kuiken and Dr. Gregory Dumanian

Targeted muscle reinnervation (TMR) is a surgical nerve-transfer procedure that was developed by Dr. Todd Kuiken and Dr. Gregory Dumanian. TMR was developed to provide amputees with more intuitive control of upper-limb prostheses by combining available technology with modifications of the residual limb anatomy. The procedure involves transferring residual nerves from the amputated limb to new muscle targets that have lost their function due to the amputation.

TMR was initially developed as a novel strategy to improve control of myoelectric upper-limb prostheses. By redirecting nerves severed by amputation to new muscle targets, TMR provides access to previously unavailable neural control information. This allows amputees to control motorized prosthetic devices and regain sensory feedback. The severed motor nerves are surgically transferred to the motor points of denervated target muscles, which, after reinnervation, contract in response to neural control signals for the missing limb.

TMR has been found to be particularly effective in reducing phantom limb pain and neuroma pain in amputees. Dr. Dumanian explains that prior to TMR, strategies to deaden the end of a painful nerve involved hiding the nerve, and TMR was the first surgery to try to heal the end of the nerve. TMR has also been found to provide sensory recovery in the skin over the muscle that was reinnervated, with patients reporting sensations in the area of the body where the missing limb once was when the reinnervated area was stimulated.

TMR has become a clinically accepted surgical procedure that has been performed over two hundred times in the US and worldwide. It has provided an exciting new way to interface with a patient's nervous system and has led to significant research and development in the field of artificial limbs.

TMR is a surgical nerve-transfer procedure

Targeted Muscle Reinnervation (TMR) is a surgical nerve-transfer procedure that provides amputees with more intuitive control of upper-limb prostheses. It was developed by Dr. Todd Kuiken of the Shirley Ryan AbilityLab and Dr. Gregory Dumanian of Northwestern Memorial Hospital's Division of Plastic Surgery. TMR has been clinically accepted and performed over 200 times in the US and worldwide.

TMR works by rerouting severed nerves to nearby muscles, allowing them to reinnervate and restore their function. Residual nerves from the amputated limb are transferred to new muscle targets that have lost their function due to the amputation. These nerves, which previously controlled the elbow, wrist, and hand, grow into and reinnervate the target muscle. The target muscles then act as biological amplifiers of the amputated nerve motor signals.

By transferring multiple nerves, TMR myoelectric signals allow intuitive, simultaneous control of multiple joints in an advanced prosthesis. This enables amputees to perform actions such as throwing a ball gracefully, exhibiting simultaneous control of the elbow and hand. TMR also provides sensory feedback, as patients have been found to experience sensation in the area of the missing limb when the skin over the reinnervated muscle is stimulated.

TMR surgery has the same risk of infection as any other soft tissue surgery, but there are some potential complications specific to the procedure. These include the risk of target muscle paralysis and neuroma pain. TMR is not suitable for patients with spinal cord injuries, brachial plexus injuries, or those who are generally not healthy enough for surgery.

TMR has provided an exciting new way to interface with a patient's nervous system and improve control of myoelectric prostheses. It has primarily been used for individuals with above-elbow amputations, but it is also being evaluated for use in transradial amputees and lower limb amputations.

TMR helps treat neuroma and phantom pain in major limb amputees

Targeted muscle reinnervation (TMR) is a surgical nerve-transfer procedure that provides amputees with intuitive control of upper-limb prostheses. It was developed by Dr. Todd Kuiken and Dr. Gregory Dumanian at Northwestern University. TMR combines available technology with modifications to the residual limb anatomy. Residual nerves from the amputated limb are transferred to new muscle targets that have lost their function. The target muscles are separated from their native motor nerve input, allowing the newly transferred nerve to reinnervate them. These reinnervated muscles then act as biological amplifiers of the amputated nerve motor signals.

TMR has been shown to be effective in treating neuroma and phantom pain in major limb amputees. Neuroma pain (NP) occurs when a trigger point, or neuroma, is disturbed by palpation or pressure, and the unpleasant paraesthesiae are localized to the area of the amputation and/or the injured nerve end. Phantom limb pain (PLP) is often perceived as paraesthesia, but differs in location, intensity, or trigger factors. TMR provides a simultaneous solution to both NP and PLP by preventing the regrowth of neuromas and addressing PLP through distant feedback to the CNS. Clinical observations indicate that TMR yields significant improvement in neuroma pain, with patients reporting high satisfaction rates.

However, TMR surgery is not without risks and potential complications. Some patients have experienced a recurrence of phantom limb pain, and the development of painful neuromas. There is also the risk of permanent paralysis of the target muscle. Additionally, TMR surgery requires specialized knowledge, surgical skills, and working practices that are not widely available.

TMR has primarily been used for individuals with above-elbow amputations, but it is being evaluated for use in transradial amputees and lower limb amputations. The benefits of TMR could provide an intuitive control interface for a large population of amputees. Furthermore, TMR does not require any implants, and existing commercially available myoelectric prostheses can be used.

TMR enables amputees to control motorized prosthetic devices and regain sensory feedback

Targeted muscle reinnervation (TMR) is a surgical nerve-transfer procedure that enables amputees to control motorized prosthetic devices and regain sensory feedback. TMR was developed by Dr. Todd Kuiken of the Shirley Ryan AbilityLab and Dr. Gregory Dumanian of Northwestern Memorial Hospital and its Division of Plastic Surgery. The procedure involves transferring residual nerves from the amputated limb to new muscle targets that have lost their function due to the amputation. These nerves, which previously controlled the elbow, wrist, and hand, are redirected to the target muscles, allowing them to reinnervate and restore their function.

TMR provides amputees with more intuitive control of upper limb prostheses by combining available technology with modifications to the residual limb anatomy. The transferred nerves act as biological amplifiers of the neuronal signals, resulting in stronger signals compared to technologies like EEG and fMRI. With TMR, multiple independent EMG signals can be produced, allowing simultaneous control of multiple functions in the prosthetic limb. For example, a patient can flex a shoulder muscle to generate an EMG signal that sends a "`bend elbow` command" to the prosthesis, enabling graceful and coordinated movements.

The goal of TMR is to transfer multiple nerves into separate regions of the targeted muscle and record multiple independent signals, allowing for sophisticated control of a motorized prosthesis. This approach is based on the hypothesis of hyper-reinnervation, which suggests that transferring an excessive number of motor neurons to a muscle can improve muscle fiber reinnervation and enhance the recovery of paralyzed muscles. TMR has been found to be particularly effective in treating neuroma and phantom limb pain, which affects approximately 55% of amputees.

While TMR has shown promising results, there are certain risks and challenges associated with the procedure. These include the possibility of permanent paralysis of the target muscle, recurrence of phantom limb pain, and the development of painful neuromas. Additionally, there may be specific complications, such as the risk of target muscle paralysis and the potential for neuroma pain due to cut nerves. TMR surgery requires careful planning and consideration of the patient's overall health and suitability for the procedure.

TMR has been clinically accepted and performed over two hundred times in the US and worldwide. It has primarily been used for individuals with above-elbow amputations, but there is ongoing research to extend its benefits to transradial amputees and lower limb amputations. TMR is a rapidly evolving field, with advancements in prosthetic technologies and the development of new mechanical and electrical interfaces.

TMR has been performed over 200 times in the US and worldwide

Targeted muscle reinnervation (TMR) is a surgical nerve-transfer procedure that was developed by Dr. Todd Kuiken and Dr. Gregory Dumanian to provide amputees with more intuitive control of upper-limb prostheses. The procedure involves redirecting nerves severed by amputation to new muscle targets, allowing for simultaneous control of multiple joints in an advanced prosthesis.

The success of TMR lies in its ability to provide intuitive control of myoelectric prostheses. By transferring multiple nerves to separate regions of the targeted muscle, independent EMG signals can be produced, allowing for multiple functions of the artificial limb to be controlled simultaneously. This is a significant improvement over traditional myoelectric prostheses, which can only perform one action at a time and require the use of muscles not normally involved in arm or wrist functions.

While TMR has been successful, it is not without risks. General surgical risks, as well as the possibility of permanent paralysis of the target muscle, recurrence of phantom limb pain, and the development of painful neuromas, are all potential complications. However, clinical observations have indicated that TMR yields significant improvement in neuroma pain, with approximately 25% of major limb amputees developing chronic localized pain due to symptomatic neuromas.

TMR continues to be an area of active research and development, with potential advances including the use of TMR in transradial amputees and new mechanical and electrical interfaces. The goal is to further improve artificial limbs and synergize TMR with emerging technologies.

Frequently asked questions